1. Infection

Infection

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14704
    2-Hydroxygentamicin C1 60609-40-7 98%
    2-Hydroxygentamicin C1 is an antibiotic of the gentamicin group with anti-Gram-positive and negative bacteria activity.
    2-Hydroxygentamicin C1
  • HY-N14705
    2-Hydroxygentamicin C2 60768-15-2 98%
    2-Hydroxygentamicin C2 is an antibiotic of the gentamicin group with anti-Gram-positive and negative bacteria activity.
    2-Hydroxygentamicin C2
  • HY-N14706
    Kibdelin A 103528-50-3 98%
    Kibdelin A is resistant to Gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as Vancomycin (HY-B0671).
    Kibdelin A
  • HY-N14707
    Kibdelin B 103528-49-0 98%
    Kibdelin B is resistant to Gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as Vancomycin (HY-B0671).
    Kibdelin B
  • HY-N14708
    Kibdelin C1 103549-47-9 98%
    Kibdelin C1 is resistant to Gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as Vancomycin (HY-B0671).
    Kibdelin C1
  • HY-N14709
    Kibdelin C2 105997-85-1 98%
    Kibdelin C2 is resistant to Gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as Vancomycin (HY-B0671).
    Kibdelin C2
  • HY-N14710
    Kibdelin D 105997-86-2 98%
    Kibdelin D is resistant to Gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as Vancomycin (HY-B0671).
    Kibdelin D
  • HY-N14711
    Himalomycin A 701915-10-8 98%
    Himalomycin A is an anthraquinone antibiotic with strong activity against Staphylococcus aureus, Escherichia coli and Streptomyces vuridochromogenes.
    Himalomycin A
  • HY-N14712
    3-O-Demethylmonensin B 109345-56-4 98%
    3-O-Demethylmonensin B is a polyether antibiotic found in Streptomyces cinnamonensis LO-63.
    3-O-Demethylmonensin B
  • HY-N14713
    Gualamycin 161017-23-8 98%
    Gualamycin has acaricidal action. 250 μg/mL of Gualamycin can completely Kill mites, which is sensitive and resistant to Dicofol.
    Gualamycin
  • HY-N14714
    Gunacin 73341-70-5 98%
    Gunacin is a quinone antibiotic. Gunacin has strong activity against Gram-positive bacteria, negative bacteria and mycoplasma.
    Gunacin
  • HY-N14716
    Haematocin 262425-39-8 98%
    Haematocin can inhibit the germination of Pyricularia oryzae spore.
    Haematocin
  • HY-N14717
    Polymyxin M 6683-17-6 98%
    Polymyxin M is a cyclic peptide antibiotic found in Bacillus polymyxa var. Ross.
    Polymyxin M
  • HY-N14718
    Porothramycin A 110652-73-8 98%
    Porothramycin A is an antibiotic. Porothramycin A has activity against Gram-positive bacteria and anaerobic bacteria.
    Porothramycin A
  • HY-N14719
    Porothramycin B 110652-72-7 98%
    Porothramycin B is an antibiotic. Porothramycin B has activity against Gram-positive bacteria and anaerobic bacteria.
    Porothramycin B
  • HY-N14720
    Demethylolivomycin A 86917-61-5 98%
    Demethylolivomycin A is an antitumor antibiotic. Demethylolivomycin A has anti-Gram-positive bacteria and anti-leukemia P388 activity.
    Demethylolivomycin A
  • HY-N14722
    Lactonamycin 182234-02-2 98%
    Lactonamycin had strong activity against Gram-positive bacteria including Staphylococcus, Streptococcus, Enterococcus, MRSA (MIC of 0.39-0.78 μg/mL) and VRE (MIC of 0.39-0.78 μg/mL). Lactonamycin also has inhibitory effect on L-1210, P388, S180, FS-3, Ehrlich, B16-BL5 and other tumor cell lines (IC50s of 0.06-3.3 μg/mL).
    Lactonamycin
  • HY-N14723
    Olivomycin B 6992-69-4 98%
    Olivomycin B has strong activity against Gram-positive bacteria and weak activity against Gram-negative bacteria.
    Olivomycin B
  • HY-N14724
    Olivomycin C 6988-59-6 98%
    Olivomycin C has strong activity against Gram-positive bacteria and weak activity against Gram-negative bacteria.
    Olivomycin C
  • HY-N14725
    Demethylolivomycin B 86917-63-7 98%
    Demethylolivomycin B is an antitumor antibiotic. Demethylolivomycin B has weak anti-Gram-positive bacteria and anti-tumor activity.
    Demethylolivomycin B
Cat. No. Product Name / Synonyms Application Reactivity